PROSTAVISION Trademark

Trademark Overview


On Wednesday, October 27, 2021, a trademark application was filed for PROSTAVISION with the United States Patent and Trademark Office. The USPTO has given the PROSTAVISION trademark a serial number of 79332912. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, February 7, 2024. This trademark is owned by ABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH. The PROSTAVISION trademark is filed in the Pharmaceutical Products category with the following description:

Medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations...
prostavision

General Information


Serial Number79332912
Word MarkPROSTAVISION
Filing DateWednesday, October 27, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, February 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording "PROSTAVISION" to the right of a design consisting of a shaded circle containing an off-center circle around which are four partial circles.
Goods and ServicesMedical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer; biological preparations for medical or pharmaceutical purposes for the treatment of cancer; preparations for use in medical diagnostic processes; preparations for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes relating to the diagnosis of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Wednesday, February 7, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, February 7, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 31, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, July 26, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 26, 2023FINAL REFUSAL E-MAILED
Wednesday, July 26, 2023FINAL REFUSAL WRITTEN
Saturday, July 15, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, July 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, June 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, June 21, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, December 5, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 5, 2022LETTER OF SUSPENSION E-MAILED
Monday, December 5, 2022SUSPENSION LETTER WRITTEN
Wednesday, November 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 25, 2022REFUSAL PROCESSED BY IB
Monday, May 2, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 2, 2022REFUSAL PROCESSED BY MPU
Saturday, March 19, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 18, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 8, 2022ASSIGNED TO EXAMINER
Tuesday, February 22, 2022APPLICATION FILING RECEIPT MAILED
Thursday, February 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 16, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 10, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB